<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">33433773</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>26</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1573-7322</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>27</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Heart failure reviews</Title>
          <ISOAbbreviation>Heart Fail Rev</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Assessing the future risks of subsequent pregnancies in peripartum cardiomyopathy.</ArticleTitle>
        <Pagination>
          <StartPage>779</StartPage>
          <EndPage>784</EndPage>
          <MedlinePgn>779-784</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10741-021-10075-z</ELocationID>
        <Abstract>
          <AbstractText>Peripartum cardiomyopathy is a myocardial disease process which occurs in young women either in late pregnancy or the early postpartum period. Due to the young age of women effected by this disease, many of these patients elect to pursue a subsequent pregnancy after their initial diagnosis. Currently, echocardiography is used to better elucidate the cardiovascular risks these young patients face when undergoing a subsequent pregnancy; however, the most accurate modality to determine these risks is debatable. In this review, we explore the current literature regarding the use and accuracy of resting transthoracic echocardiography, exercise stress echocardiography, and dobutamine stress echocardiography in risk stratification of a subsequent pregnancy in a patient with peripartum cardiomyopathy.</AbstractText>
          <CopyrightInformation>© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Port</LastName>
            <ForeName>Zachary</ForeName>
            <Initials>Z</Initials>
            <Identifier Source="ORCID">0000-0002-5726-0335</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Division of Cardiology, Einstein Medical Center, Philadelphia, PA, USA. portzach@einstein.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ammari</LastName>
            <ForeName>Zaid</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Division of Cardiology, Einstein Medical Center, Philadelphia, PA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Babapoor-Farrokhran</LastName>
            <ForeName>Savalan</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Division of Cardiology, Einstein Medical Center, Philadelphia, PA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bozorgnia</LastName>
            <ForeName>Behnam</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Division of Cardiology, Einstein Medical Center, Philadelphia, PA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>01</Month>
          <Day>12</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Heart Fail Rev</MedlineTA>
        <NlmUniqueID>9612481</NlmUniqueID>
        <ISSNLinking>1382-4147</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058725" MajorTopicYN="N">Peripartum Period</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011249" MajorTopicYN="Y">Pregnancy Complications, Cardiovascular</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011644" MajorTopicYN="Y">Puerperal Disorders</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Cardiomyopathy</Keyword>
        <Keyword MajorTopicYN="Y">Dobutamine stress echocardiography</Keyword>
        <Keyword MajorTopicYN="Y">Exercise stress echocardiography</Keyword>
        <Keyword MajorTopicYN="Y">PPCM</Keyword>
        <Keyword MajorTopicYN="Y">Peripartum cardiomyopathy</Keyword>
        <Keyword MajorTopicYN="Y">Prognosis</Keyword>
        <Keyword MajorTopicYN="Y">SSP</Keyword>
        <Keyword MajorTopicYN="Y">Stress echocardiography</Keyword>
        <Keyword MajorTopicYN="Y">Subsequent pregnancy</Keyword>
        <Keyword MajorTopicYN="Y">Systolic heart failure</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>1</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>1</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>1</Month>
          <Day>12</Day>
          <Hour>12</Hour>
          <Minute>23</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33433773</ArticleId>
        <ArticleId IdType="doi">10.1007/s10741-021-10075-z</ArticleId>
        <ArticleId IdType="pii">10.1007/s10741-021-10075-z</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Kolte D et al (2014) Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: A Nationwide Population‐Based Study. JAHA vol. 3</Citation>
        </Reference>
        <Reference>
          <Citation>Isezuo S, Abubakar S (2007) Epidemiologic profile of peripartum cardiomyopathy in a tertiary care hospital. Ethn Dis 17:228–233</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17682350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fett JD, Christie LG, Carraway RD, Murphy JG (2005) Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc 80:1602–1606</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4065/80.12.1602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kamiya CA et al (2011) Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. Circ J 75:1975–1981</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1253/circj.CJ-10-1214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hess RF, Weinland JAD (2012) The life-changing impact of peripartum cardiomyopathy: an analysis of online postings. MCN: The American Journal of Maternal/Child Nursing 37:241–246</Citation>
        </Reference>
        <Reference>
          <Citation>Irizarry OC et al (2017) Comparison of clinical characteristics and outcomes of peripartum cardiomyopathy between African American and non-African American women. JAMA Cardiology 2:1256</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamacardio.2017.3574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McNamara DM et al (2015) Clinical outcomes for peripartum cardiomyopathy in North America. J Am Coll Cardiol 66:905–914</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jacc.2015.06.1309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Honigberg MC, Givertz MM (2019) Peripartum cardiomyopathy. BMJ k5287 https://doi.org/10.1136/bmj.k5287 .</Citation>
        </Reference>
        <Reference>
          <Citation>Modi KA, Illum S, Jariatul K, Caldito G, Reddy PC (2009) Poor outcome of indigent patients with peripartum cardiomyopathy in the United States. Am J Obstet Gynecol 201(171):e1-171.e5</Citation>
        </Reference>
        <Reference>
          <Citation>Habli M et al (2008) Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome. Am J Obstet Gynecol 199(415):e1-415.e5</Citation>
        </Reference>
        <Reference>
          <Citation>Fett JD, Fristoe KL, Welsh SN (2010) Risk of heart failure relapse in subsequent pregnancy among peripartum cardiomyopathy mothers. International Journal of Gynecology &amp; Obstetrics 109:34–36</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijgo.2009.10.011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hilfiker-Kleiner D et al (2007) A Cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 128:589–600</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2006.12.036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chapa JB et al (2005) Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet Gynecol 105:1303–1308</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.AOG.0000161382.30233.ba</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Avila WS et al (2002) Pregnancy and peripartum cardiomyopathy. A comparative and prospective study. Arq Bras Cardiol 79:484–493</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S0066-782X2002001400006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sliwa K et al (2004) Outcome of subsequent pregnancy in patients with documented peripartum cardiomyopathy. Am J Cardiol 93(1441–1443):A10</Citation>
        </Reference>
        <Reference>
          <Citation>Elkayam U et al (2001) Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 344:1567–1571</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJM200105243442101</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mandal D et al (2011) Pregnancy and subsequent pregnancy outcomes in peripartum cardiomyopathy: pregnancy in peripartum cardiomyopathy. J Obstet Gynaecol Res 37:222–227</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1447-0756.2010.01378.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chee K, Azman W (2009) Prevalence and outcome of peripartum cardiomyopathy in Malaysia. Int J Clin Pract 63:722–725</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1742-1241.2007.01449.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Al Bannay R, Husain A, AlJufairi Z (2017) Peripartum cardiomyopathy, what if your patient plans to reconceive? Clin Case Rep 5:753–756</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ccr3.935</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>St. John Sutton M, Cole P, Plappert M, Saltzman D, Goldhaber S, (1991) Effects of subsequent pregnancy on left ventricular function in peripartum cardiomyopathy. Am Heart J 121:1776–1778</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0002-8703(91)90025-D</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sliwa K et al (2018) Long-term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy: Long-term prognosis and management of PPCM. Eur J Heart Fail 20:951–962</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ejhf.1178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hilfiker-Kleiner D et al (2017) Outcome of subsequent pregnancies in patients with a history of peripartum cardiomyopathy. Eur J Heart Fail 19:1723–1728</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ejhf.808</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Codsi E, Rose CH, Blauwet LA (2018) Subsequent pregnancy outcomes in patients with peripartum cardiomyopathy. Obstet Gynecol 131:322–327</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/AOG.0000000000002439</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Albanesi F<sup>o</sup>, F. M. &amp; Silva, T. T. da. Natural course of subsequent pregnancy after peripartum cardiomyopathy. Arq Bras Cardiol 73:53–57</Citation>
        </Reference>
        <Reference>
          <Citation>Sugahara M et al (2019) Global left ventricular strain at presentation is associated with subsequent recovery in patients with peripartum cardiomyopathy. J Am Soc Echocardiogr 32:1565–1573</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.echo.2019.07.018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Keren AMEB, Weintraub D, EB S, RL P, (1985) Mildly dilated congestive cardiomyopathy. Circulation 72:302–309</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.CIR.72.2.302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gayazzi A et al (1993) The spectrum of left ventricular size in dilated cardiomyopathy: clinical correlates and prognostic implications. Am Heart J 125:410–422</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0002-8703(93)90020-A</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lampert MB et al (1997) Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function. Am J Obstet Gynecol 176:189–195</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0002-9378(97)80034-8</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nagaoka H et al (1997) Myocardial contractile reserve as prognostic determinant in patients with idiopathic dilated cardiomyopathy without overt heart failure. Chest 111:344–350</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.111.2.344</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marmor A, Schneeweiss A (1997) Prognostic value of noninvasively obtained left ventricular contractile reserve in patients with severe heart failure. J Am Coll Cardiol 29:422–428</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0735-1097(96)00493-7</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dubois-Randé J-L et al (1992) β-Adrenergic contractile reserve as a predictor of clinical outcome in patients with idiopathic dilated cardiomyopathy. Am Heart J 124:679–685</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0002-8703(92)90278-4</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cigarroa CG, Alvarez LG, Wait MA, Grayburn PA (1993) Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 430–436</Citation>
        </Reference>
        <Reference>
          <Citation>Naqvi TZ, Goel RK, Forrester JS, Siegel RJ (1999) Myocardial contractile reserve on dobutamine echocardiography predicts late spontaneous improvement in cardiac function in patients with recent onset idiopathic dilated cardiomyopathy. J Am Coll Cardiol 34:1537–1544</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0735-1097(99)00371-X</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>La Canna G, Alfieri O, Giubbini R (1994) Echocardiography during infusion of dobutamine for identification of reversible dyfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 23:617–626</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0735-1097(94)90745-5</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blomstrand P, Thulesius O, Wranne B (1995) Cardiovascular effects of dobutamine stress testing in healthy women. Clin Cardiol 18:659–663</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/clc.4960181113</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thornburg KL, Jacobson S-L, Giraud GD, Morton MJ (2000) Hemodynamic changes in pregnancy. Semin Perinatol 24:11–14</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0146-0005(00)80047-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andersen M, Olson T, Melenovsky V (2015) Differential hemodynamic effects of exercise and volume expansion in people with and without heart failure. Circ&amp;nbsp;Heart&amp;nbsp;Fail 8:41–48</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.114.001731</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dorbala S et al (2005) Risk stratification of women with peripartum cardiomyopathy at initial presentation: a dobutamine stress echocardiography study. J Am Soc Echocardiogr 18:45–48</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.echo.2004.08.027</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barbosa MM et al (2012) Rest left ventricular function and contractile reserve by dobutamine stress echocardiography in peripartum cardiomyopathy. Rev Port Cardiol 31:287–293</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.repc.2012.02.002</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
